207 related articles for article (PubMed ID: 16998758)
1. Intravenous immunoglobulin therapy in neurological diseases during pregnancy.
Ringel I; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V70-4. PubMed ID: 16998758
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
Dudesek A; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754
[TBL] [Abstract][Full Text] [Related]
3. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
5. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment on anti-GM1 antibodies associated neuropathies inhibits cholera toxin and galectin-1 binding to ganglioside GM1.
Peng W
Immunol Lett; 2012 Apr; 143(2):146-51. PubMed ID: 22289946
[TBL] [Abstract][Full Text] [Related]
7. Advances in the use of IVIg in neurological disorders.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():1-2. PubMed ID: 18685918
[No Abstract] [Full Text] [Related]
8. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immune globulin in autoimmune and inflammatory diseases.
Gelfand EW
N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
[No Abstract] [Full Text] [Related]
10. Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
Sanchez-Ramon S; Corbi AL; Fidalgo AG; Dominguez-Soto A
Curr Pharm Des; 2016; 22(41):6300-6305. PubMed ID: 27587200
[TBL] [Abstract][Full Text] [Related]
11. [High Dose Intravenous Immunoglobulin Therapy for Autoimmune Diseases of the Central Nervous System].
Uzawa A; Kuwabara S
Brain Nerve; 2021 May; 73(5):420-424. PubMed ID: 34006671
[TBL] [Abstract][Full Text] [Related]
12. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for autoimmune autonomic ganglionopathy.
Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
[TBL] [Abstract][Full Text] [Related]
14. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Stangel M; Gold R
Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure.
Bentley P; Rosso M; Sadnicka A; Israeli-Korn S; Laffan M; Sharma P
J Clin Pharm Ther; 2012 Jun; 37(3):286-90. PubMed ID: 21767284
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulins and physiopathology: actual indications].
Mouthon L; Guilpain P
Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
[TBL] [Abstract][Full Text] [Related]
17. Acute dysautonomia: complete recovery after two courses of IVIg.
Ishitobi M; Haginoya K; Kitamura T; Munakata M; Yokoyama H; Iinuma K
Brain Dev; 2004 Dec; 26(8):542-4. PubMed ID: 15533658
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin and quality of life.
Padua L; Aprile I; Caliandro P; Pazzaglia C; Tonali P
JAMA; 2004 Sep; 292(12):1429; author reply 1429-30. PubMed ID: 15383509
[No Abstract] [Full Text] [Related]
[Next] [New Search]